Search

Search Constraints

You searched for: Author/Creator Yoshitake, Tadamasa

Search Results

1. ACT-16 THE POTENTIAL OF HYPOFRACTIONATED RADIOTHERAPY AND BEVACIZUMAB FOR GLIOBLASTOMA TREATMENT. (16th December 2019)

3. Clinical significance of CDKN2A homozygous deletion in combination with methylated MGMT status for IDH‐wildtype glioblastoma. (10th April 2021)

6. Skeletal muscle area predicts the outcomes of non-small-cell lung cancer after trimodality therapy. Issue 2 (25th January 2023)

7. Stereotactic body radiotherapy to treat small lung lesions clinically diagnosed as primary lung cancer by radiological examination: A prospective observational study. (August 2018)